海外の治験の状況「前立腺癌」での検索結果
118件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- A Randomized Double-Blind Phase 3 Trial Comparing Docetaxel Combined with Dasatinib to Docetaxel Combined with Placebo in Castration-Resistant Prostate Cancer
- Castration-Resistant Prostate Cancer br>C04.588.945.440.770 C61;C00-D48;C04.588.945.440.770
- Australia, Brazil, Canada, Czech Republic, Finland, France, Germany, Greece, Hungary, India, Italy, Korea, Republic of, Norway, Poland, Romania, Russian Federation, South Africa, Switzerland, United Kingdom, United States
- 2011-06-13
Not Recruiting
- Cabazitaxel versus Docetaxel both with Prednisone in Patients with Metastatic Castration Resistant Prostate Cancer
- metastatic Castration Resistant Prostate cancer br>MedDRA version: 14.1 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- Brazil, Canada, Czech Republic, Denmark, European Union, Finland, Germany, Israel, Italy, Mexico, Peru, Poland, Portugal, Russian Federation, Spain, Sweden, Taiwan, Turkey
- 2011-01-28
Not recruiting
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
- Prostate Cancer
- Canada, Peru, United States
- 2007-01-30
Not Recruiting
- A Randomized Double-Blind Phase 3 Trial Comparing Docetaxel Combined With Dasatinib to Docetaxel Combined With Placebo in Castration-Resistant Prostate Cancer
- Prostatic Neoplasms;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Brazil, Canada, Czech Republic, Finland, France, Germany, Greece, Hungary, India, Ireland, Italy, Korea, Republic of, Mexico, Norway, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Sweden, United Kingdom, United States
- 2012-10-18
Not Recruiting
- A Randomized, Double-Blind, Phase 3 Trial Comparing Ipilimumab vs. Placebo Following Radiotherapy in Subjects With Castration Resistant Prostate Cancer That Have Received Prior Treatment With Docetaxel
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Peru, Poland, Puerto Rico, Romania, Russian Federation, Spain, United Kingdom, United States
- 2015-11-12
Not Recruiting
- A Phase III Trial to Test the Efficacy of ZD4054(Zibotentan), an Endothelin A Receptor Antagonist, Versus Placebo in Patients With Hormone Resistant Prostate Cancer (HRPC) and Bone Metastasis Who Are Pain Free and Mildly Symptomatic.
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Hong Kong, Hungary, India, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Russian Federation, Serbia, Singapore, South Africa, Sweden, Switzerland, Taiwan, Province of China, United Kingdom, United States
- 2015-11-11
Not recruiting
- A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer
- Prostate Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Chile, China, Czechia, France, Germany, Hong Kong, Israel, Italy, Mexico, New Zealand, Poland, Romania, Russian Federation, Singapore, Spain, Turkey, United Kingdom, United States
- 2019-09-20
Not recruiting
- Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide
- Prostate Cancer;Castration-resistant Prostate Cancer
- Brazil
- 2018-09-14
Not recruiting
- Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms
- Prostatic Neoplasms
- Australia, Belgium, Brazil, Canada, Finland, France, Germany, Israel, Italy, Japan, Netherlands, Norway, Poland, Russian Federation, Singapore, Spain, Sweden, United Kingdom, United States
- 2014-01-21
Not recruiting
- Study of Irofulven in Patients With Hormone-refractory Prostate Cancer
- Prostate Cancer
- Brazil, Canada, Chile, Croatia, France, Peru, Romania, Russian Federation, United States
- 2005-07-26